Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.

Source:http://linkedlifedata.com/resource/pubmed/id/17264944

Download in:

View as

General Info

PMID
17264944